CRISPR Therapeutics AG

NasdaqGM:CRSP

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

Location

Switzerland

Market Cap

USD 5.59 B

Share Price

USD 64.76

Avg Daily Volume

2,587,653

Change (1 day)

-1.97%

Change (1 year)

12.49%

Change (YTD)

64.53%

CRISPR Therapeutics AG Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 0.43

CRISPR Therapeutics AG Revenue Per Share is USD 0.43 for the Trailing 12 Months (TTM) ending March 31, 2025, a -87.19% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

CRISPR Therapeutics AG Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 3.38, a 163.38% change year over year.
CRISPR Therapeutics AG Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.28, a -89.25% change year over year.
CRISPR Therapeutics AG Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 11.95, a 140,286.79% change year over year.
CRISPR Therapeutics AG Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 0.01, a -99.83% change year over year.